全国垂询热线
020-84128820


新闻资讯

联系我们

广州市雨纯生物科技有限公司
全国垂询热线:020-84128820
传真:020-84128836
地址:广州市增城中新镇福和坪中南路151号

Prospects for medical dressing industry: we should seize the opportunity to reshape the fundamentals
专栏:Industry News
发布日期:2016-01-12
阅读量:2405
作者:佚名
收藏:
  [China Pharmaceutical Network Market Analysis] It can be said that in the past 30 years, the development of the medical dressing industry in China's manufacturing industry is relatively good. Curre...
   [China Pharmaceutical Network Market Analysis] It can be said that in the past 30 years, the development of the medical dressing industry in China's manufacturing industry is relatively good. Currently, the global medical dressing industry is still mainly concentrated in China. Prospects for medical dressing industry: we should seize the opportunity to reshape the fundamentals Medical dressings are sanitary materials, which have always occupied a large proportion in China's export trade. At present, China's medical dressing exports have accounted for more than 20% of the total export of medical dressings worldwide. According to the statistics of China Chamber of Commerce for Import and Export of Medicines and Health Products, in the first quarter of this year, China's medical dressings exported 565 million US dollars, an increase of 11.56%, accounting for 13.33% of China's total medical equipment exports in the same period. The top three export destination markets are North America. , Europe, Asia.

"Although the export still maintains a relatively high growth rate, it is necessary to pay attention to the fact that the export of medical dressings in China and the United States has shown a saturated trend. In addition, the competition in the same industry is fierce. A considerable number of export enterprises have turned their target markets to Saudi Arabia, Brazil and Emerging markets such as Russia. It is foreseeable that in the future, China's medical dressing industry will face more difficulties and more intense market competition.” Recently, Professor Pei Tingfei from the Institute of Interdisciplinary Studies at Peking University held the “Camel Man Eighth in 2015” in Henan. The analysis of the China Medical Consumables Conference pointed out.

       New difficulties continue to emerge

       It should be said that in the past 30 years, the development of the medical dressing industry in China's manufacturing industry is relatively good. Currently, the global medical dressing industry is still mainly concentrated in China. According to Cui Jinhai, president of Ogilvy Medical, who has more than 30 years of experience in the medical dressing industry, according to him, China's medical dressing industry has generally experienced four stages.

       The first phase began in the mid-1980s, when the industry supplied a single product – mainly raw gauze; the second phase was in the 1990s, when companies began to purchase large quantities of raw materials for further processing, and then shipped the products to Europe. Packaging in North America and other regions, at this stage, raw material supply and enterprises are diversified, and the industry is gradually growing. The third phase begins in the early 21st century, and the industry develops into deep processing and packaging production. At this stage, the industry enjoys China. Market dividends and demographic dividends, many companies began to transform and upgrade, from the development of primary raw materials to the integrated design of products, equipment, plants, the products are more refined, the cost is almost controlled to the "extreme", pushing the development of the industry To the climax, a number of leading enterprises such as Steady, Ogilvy and Zhende have been achieved.

    "However, when the industry develops to the fourth stage, you will find that the market's 'winding' is not so good, the original population and market dividends are getting less and less, and the industrial development faces many new difficulties." Cui Jinhai The words turned to say that at present, China's medical dressing industry faces obvious difficulties in terms of order pressure, raw material prices, corporate funds, labor costs, environmental responsibility, and risk control.

       Regarding the impact of fluctuations in the price of raw materials for medical dressings on production companies, it has already caused a great reaction in the industry. Cui Jinhai has repeatedly commented on this issue in public. He pointed out at this meeting that the main raw material for medical dressings is cotton. However, in recent years, China's cotton prices have fluctuated volatility, with a maximum of 27,000 yuan per ton and a minimum of 10,000 yuan per ton.

In terms of funds, the capital flow of the original industry is very good. Many enterprises are doing developed markets. Now some enterprises have a large “volume”. Under the circumstance of fluctuations in raw and auxiliary materials prices, funds are getting tighter. . In terms of labor costs, the average monthly wage of ordinary workers in medical dressing production enterprises does not exceed 200 yuan, and now it is 2,500-2,600 yuan, which does not include social security. For example, enterprises are facing the situation of low-end talent costs and difficulties in introducing high-end talents.

       At present, the demand for traditional export markets in Europe, the United States and Japan tends to be saturated, domestic prices have risen rapidly, labor, raw materials, and freight costs have increased correspondingly, resulting in an increase in export trade quotations. Domestically produced medical dressings that have been superior in cost-effectiveness have been on the international market. The competitive advantage is weakening. In addition, the currency of Southeast Asian countries has gradually depreciated. In addition, the labor and raw material costs of these countries are relatively low, and the price advantage of their products has gradually emerged, occupying a certain market. At the same time, international trade protectionism has risen, and Europe and the United States have restricted the export of medical dressings in China by raising non-tariff barriers such as quality thresholds, anti-dumping and countervailing.

      In recent years, domestic manufacturing industry has generally faced new problems of increasing energy and environmental responsibility. In Cui Jinhai's view, although the medical dressing industry is not as stressed as other manufacturing industries in terms of energy consumption and environmental protection, it has encountered a lot of problems in energy. "The price of electricity is too high, the quality of electricity is unstable, and the impact on production equipment is very large.

We invested hundreds of thousands of dollars to introduce foreign equipment to control the problem of voltage instability. He also pointed out that domestic enterprises are also facing new problems in their risk control capabilities. Some enterprises have demands to enter the capital market, but it is necessary to know that listing is a "double-edged sword" for enterprises, and enterprises are in the capital market. It seems very weak, and the ending of financing may also make some good companies become less healthy.

       Due to the relatively low barriers to entry in the industry, the homogenization of domestic medical dressing products is serious, forming a vicious circle of low-price competition. In addition, export medical dressing products are mainly exported by OEM, and few domestic enterprises have their own brands in the international market. Some export companies lack their own export sales channels, and the products mainly rely on foreign distributors.

Grasping the opportunity to reshape the fundamentals

       Although the medical dressing manufacturing industry faces complicated situations and difficulties, many experts in the meeting are still optimistic about the prospects of the international medical dressing market. According to the analysis of the professionals of the Medical Insurance Chamber of Commerce, there are still huge business opportunities in the current medical dressing market. Domestic enterprises should actively respond to difficulties and “break the ice”.

    "With the increasing aging of the global population and the increase in the number of patients with ulcers, hemorrhoids and other diseases, the demand for international medical dressings will continue to grow. With the advancement of medical reform in China and the development of individualized treatment, As well as changes in population structure, China's medical dressing manufacturing industry will usher in a period of rapid development."

      Yan Tingfei pointed out that the State Council announced "Made in China 2025" on May 8 this year, proposing three 10-year "three-step" strategy for China's manufacturing powerhouse construction, and clearly stated in the "Ten Key Development Areas" that it should be improved. The innovative ability and industrialization level of medical devices, focusing on the development of high-performance medical equipment such as imaging equipment and medical robots, high-value medical consumables such as fully degradable vascular stents, mobile medical products such as wearable and remote medical treatment, and realization of biological 3D printing and induction. Breakthroughs and applications of new technologies such as stem cells. This will greatly promote the development of medical devices and medical dressings in China. (Source: China Medical News)

For more information about our products, please contact: 13418647740

上一页:Increased policy support and broad medical equipment market
下一页:Informatization and Hundreds of Flowers, Internet and Medical New Thinking Mode Will Be Realized

在线客服

在线客服
联系方式

全国热线:020-84128820